文献速递瓣膜病与结构性心脏病

揭示瓣膜性心脏病机制以确定药物治疗靶点:美国心脏协会科学声明

Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2024-06-17

该科学声明综述了人类心脏瓣膜的基本细胞结构及其在原发性瓣膜性心脏病中的变化,聚焦钙化性主动脉瓣狭窄、二叶式主动脉瓣、二尖瓣脱垂和风湿性心脏病,概述了各病的分子发现及潜在治疗靶点,并指出未来研究需填补的知识空白。

要点

  • 原发性瓣膜性心脏病缺乏有效药物治疗,重度病变需瓣膜置换。
  • 钙化性主动脉瓣狭窄、二叶式主动脉瓣、二尖瓣脱垂和风湿性心脏病是重点关注的常见原发性瓣膜病。
  • 声明梳理了各病的分子通路发现与潜在药物靶点,并指出向临床试验转化的关键挑战。

核心结论

  • 瓣膜性心脏病全球常见且无有效药物治疗,需阐明分子机制以发现可进入临床试验的靶点。

研究设计与样本

  • 美国心脏协会科学声明,综述人类心脏瓣膜基本细胞结构及原发性瓣膜病中的改变。

主要发现

  • 综述聚焦钙化性主动脉瓣狭窄、二叶式主动脉瓣、二尖瓣脱垂和风湿性心脏病,概述了各病的基本分子发现。

临床怎么用

  • 声明提出原发性瓣膜性心脏病的潜在治疗分子靶点,并讨论了将研究转化为可行靶点的关键挑战。

局限性

  • 声明指出将瓣膜病研究转化为可推进临床试验并有效预防或改变病程的分子靶点仍存在关键挑战与知识空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Valvular heart disease is a common cause of morbidity and mortality worldwide and has no effective medical therapy. Severe disease is managed with valve replacement procedures, which entail high health care-related costs and postprocedural morbidity and mortality. Robust ongoing research programs have elucidated many important molecular pathways contributing to primary valvular heart disease. However, there remain several key challenges inherent in translating research on valvular heart disease to viable molecular targets that can progress through the clinical trials pathway and effectively prevent or modify the course of these common conditions. In this scientific statement, we review the basic cellular structures of the human heart valves and discuss how these structures change in primary valvular heart disease. We focus on the most common primary valvular heart diseases, including calcific aortic stenosis, bicuspid aortic valves, mitral valve prolapse, and rheumatic heart disease, and outline the fundamental molecular discoveries contributing to each. We further outline potential therapeutic molecular targets for primary valvular heart disease and discuss key knowledge gaps that might serve as future research priorities.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Small AM, Yutzey KE, Binstadt BA, et al. Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 38881493. doi:10.1161/CIR.0000000000001254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。